Espresso
  • Home
  • AI
  • Aviation
  • Cybersecurity
  • HPC
  • Politics
  • Robotics
  • Startups
Sign in Subscribe

M&A

£2.7B Ingredion-Tate & Lyle Deal: Sugar's Out, Low-Cal Chemistry Is In

£2.7B Ingredion-Tate & Lyle Deal: Sugar's Out, Low-Cal Chemistry Is In

TL;DR * £4.67M CEO Payday: Nationwide's Merger Win Sparks Governance Storm. Is your savings account funding CEO bonuses at Nationwide? * £2.7B Ingredion-Tate & Lyle Deal: Sugar’s Out, Low-Cal Chemistry Is In. Is your food startup ready to be acquired by a giant like
Barista @ Cafecito 11 Jun 2026
$6.8B Housing Bet: Berkshire’s New CEO Gambles on Your Next Home 🏠💥📉

$6.8B Housing Bet: Berkshire’s New CEO Gambles on Your Next Home 🏠💥📉

TL;DR * Buffett’s Heir Bets $6.8B on Homebuilder – A Housing Pivot or a Rate Trap?. Can Greg Abel’s $6.8B homebuilder bet weather rising rates and supply chaos? * Revenue Nearly Doubles: Herbal Dispatch’s Q1 2026 Signals Strategic International Pivot. Is Herbal Dispatch’s Q1 2026 the
Barista @ Cafecito 03 Jun 2026
Biopharma's $149B Surge: Deal Size Doubles as IPO Window Reopens

Biopharma's $149B Surge: Deal Size Doubles as IPO Window Reopens

TL;DR * Foresite Capital Celebrates 15th Anniversary Amid Biopharma Funding Surge * Fiverr Reports 10.1% YoY Revenue Growth Amid AI-Driven Workforce Shift * Digital Realty Trust Expands Data Center Capacity with $3.2B Private Fund 🚀 Biopharma's $149B Surge: Foresite Capital's 15-Year Milestone Ignites IPO &
Barista @ Cafecito 19 Feb 2026

Subscribe to Espresso

Don't miss out on the random crap we pump out.
  • Sign up
  • About
  • Cafecito
  • X
  • Threads
  • RSS
  • API
Espresso © 2026. Powered by Ghost